Ticker
GLAXO
Financial health
Glaxosmithkline Pharmaceuticals Limited Financial health
Financial health for Glaxosmithkline Pharmaceuticals Limited (GLAXO) on 6ix covers company data, market context, news, risks, and AI research briefs.
Glaxosmithkline Pharmaceuticals Limited
Glaxosmithkline Pharmaceuticals Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GLAXO.
Stock profile
Asset type
Stock
Market cap
$4.07B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
INR
Ticker listings
Glaxosmithkline Pharmaceuticals Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- GLAXO primary listing
Research sections
Valuation
Review valuation context for Glaxosmithkline Pharmaceuticals Limited.
Future growth
Review future growth context for Glaxosmithkline Pharmaceuticals Limited.
Past performance
Review past performance context for Glaxosmithkline Pharmaceuticals Limited.
Financial health
Review financial health context for Glaxosmithkline Pharmaceuticals Limited.
Dividend
Review dividend context for Glaxosmithkline Pharmaceuticals Limited.
Management
Review management context for Glaxosmithkline Pharmaceuticals Limited.
Ownership
Review ownership context for Glaxosmithkline Pharmaceuticals Limited.
Other information
Review other information context for Glaxosmithkline Pharmaceuticals Limited.
Community
Review community context for Glaxosmithkline Pharmaceuticals Limited.